Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Gynecol Oncol. 2013 Oct 29;132(1):166–175. doi: 10.1016/j.ygyno.2013.10.027

Fig. 4.

Fig. 4

Reverse-phase protein array for PDGFRα blockade in ovarian carcinoma. Heatmap of reverse-phase protein array (RPPA) results in HeyA8-MDR (PDGFRα-sensitive cell line) treated with PDGF-AA and IMC-3G3 at an early time point (6 h) and late time point (24 h).